TD Securities cut shares of Trilogy International Partners (TSE:TRL) from a buy rating to a hold rating in a research note issued to investors on Monday morning, BayStreet.CA reports. The brokerage currently has C$2.25 price objective on the specialty pharmaceutical company’s stock, down from their prior price objective of C$3.25.
Trilogy International Partners has a one year low of C$1.44 and a one year high of C$3.45. The firm has a market capitalization of $94.49 million and a price-to-earnings ratio of -4.80. The company’s 50 day simple moving average is C$1.76 and its 200 day simple moving average is C$1.96.
Trilogy International Partners Company Profile
Further Reading: Google Finance Portfolio Tips and Tricks
Receive News & Ratings for Trilogy International Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trilogy International Partners and related companies with MarketBeat.com's FREE daily email newsletter.